# Helus Pharma Discusses Mental Health Drug Strategy

> Helus Pharma reveals Phase 3 plans for new mental health drugs targeting serotonin pathways.
- Title: Helus Pharma Discusses Mental Health Drug Strategy | Shortify
- Summary: Helus Pharma reveals Phase 3 plans for new mental health drugs targeting serotonin pathways. Helus Pharma announced Phase 3 clinical trials for novel…
- Keywords: helus pharma, serotonergic agonists, phase 3 trials, mental health, clinical pipeline, nasdaq:help, money, business, Helus, Pharma, Discusses, Mental
- Source: Seekingalpha — https://seekingalpha.com/article/4957129-helus-pharma-inc-help-discusses-clinical-pipeline-and-phase-3-strategies-for-novel
- Author: SA Transcripts
- Published: 2026-10-23T23:11:24+00:00
- Read time: 1 min
- Topics: helus pharma, serotonergic agonists, phase 3 trials, mental health, clinical pipeline, nasdaq:help, money, business
## Helus Pharma
Helus Pharma Inc. published a slide deck discussing clinical pipeline and Phase 3 strategies for novel serotonergic agonists in mental health.
## Phase 3 Strategy
The company outlined plans for Phase 3 clinical trials targeting mental health conditions through serotonergic agonists.
## Clinical Pipeline
Helus Pharma's clinical pipeline focuses on novel serotonergic agonists for mental health treatment development.
## Key takeaway

Helus Pharma announced Phase 3 clinical trials for novel serotonergic agonists to treat mental health conditions.